LINBID 600 Tablet

About LINBID 600 Tablet

Made by Biopharma Ltd., LINBID 600 is a tablet whose active ingredient is Linezolid. This medicine is not for viral infections such as colds or flu.

There are 39 brands of Linezolid listed in Bangladesh. The lowest listed price is Linez 400 mg Tablet at ৳ 60.00 per unit.

What is LINBID 600 Tablet?

LINBID 600 comes as a tablet with 600 mg of Linezolid, from Biopharma Ltd. Linezolid works by stopping bacteria from making proteins, which is different from how many other antibiotics work. This action is different from many other antibiotics, which helps it remain effective against some resistant bacteria. Whether it suits you is a decision for your doctor.

Uses of LINBID 600

This medicine is not for viral infections such as colds or flu. LINBID 600 600 mg tablet is used to treat infections caused by certain Gram-positive bacteria, such as hospital-acquired pneumonia and vancomycin-resistant Enterococcus faecium infections, including those with bacteria in the blood. It may be used alone or with other medicines. Your doctor will decide if it is suitable for you.

How to use LINBID 600

Swallow the tablet whole with water. LINBID 600 is taken by mouth. If a dose is missed, ask the doctor or pharmacist for advice. The dose and length of treatment are decided by your doctor based on your condition.

Side effects of LINBID 600

Contact the doctor if you have repeated nausea or vomiting, or if you feel unwell in a way that worries you. Common side effects include diarrhoea, headache and nausea. Contact your doctor if you notice anything unusual after taking it. Contact your doctor if side effects are troublesome or do not go away.

Safety and precautions

Pregnancy category C: use only if the benefit justifies the risk. This medicine is not recommended for people with uncontrolled high blood pressure, pheochromocytoma, thyrotoxicosis, or carcinoid syndrome, or those taking certain sympathomimetic agents. LinLINBID 600 may interact with serotonergic medicines, so close monitoring is needed. Ask your doctor first if any of these apply to you.

Frequently asked questions

What does LINBID 600 treat?

This medicine is not for viral infections such as colds or flu. LINBID 600 600 mg tablet is used to treat infections caused by certain Gram-positive bacteria, such as hospital-acquired pneumonia and vancomycin-resistant Enterococcus faecium infections, including those with bacteria in the blood.

How is LINBID 600 used?

Swallow the tablet whole with water. LINBID 600 is taken by mouth.

What are the side effects of LINBID 600?

Contact the doctor if you have repeated nausea or vomiting, or if you feel unwell in a way that worries you. Common side effects include diarrhoea, headache and nausea.

Is LINBID 600 safe for everyone?

Pregnancy category C: use only if the benefit justifies the risk. This medicine is not recommended for people with uncontrolled high blood pressure, pheochromocytoma, thyrotoxicosis, or carcinoid syndrome, or those taking certain sympathomimetic agents.

Indications

Vancomycin-Resistant Enterococcus faecium infections including cases with concurrent bacteremia.

Nosocomial pneumonia caused by Staphylococcus aureus (methicillin-susceptible and -resistant strains) or Streptococcus pneumoniae (including multi-drug resistant strains). Combination therapy ... Read moreVancomycin-Resistant Enterococcus faecium infections including cases with concurrent bacteremia.

Nosocomial pneumonia caused by Staphylococcus aureus (methicillin-susceptible and -resistant strains) or Streptococcus pneumoniae (including multi-drug resistant strains). Combination therapy may be clinically indicated if the documented or presumptive pathogens include Gram-negative organism.

Complicated skin and skin structure infections, including diabetic foot infections (without concomitant osteomyelitis) caused by Staphylococcus aureus (methicillin-susceptible and methicillin-resistant strains), Streptococcus pyogenes or Streptococcus agalactiae.

Uncomplicated skin and skin structure infections caused by Staphylococcus aureus (methicillin-susceptible only) or Streptococcus pyogenes.

Community-acquired pneumonia caused by Streptococcus pneumoniae (including multi-drug resistant strains) including cases with concurrent bacteremia or Staphylococcus aureus (methicillin-susceptible strains only).

Pharmacology

Linezolid is a synthetic, antibacterial agent belonging to a new class of antibiotics, the oxazolidinones, with in vitro activity against Gram positive aerobic bacteria, some Gram positive anaerobic bacteria and certain Gram negative bacteria. It selectively inhibits bacterial protein synthesis via a mechanism of action different from that of other antibacterial agents. Linezolid binds to the 23S ribosomal RNA of the 50S subunit of the bacterial ribosome and prevents the formation of a functional 70S initiation complex which is an essential component of the bacterial translation process. The results of time-kill studies have shown Linezolid to be bacteriostatic against enterococci and staphylococci. For streptococci, Linezolid was found to be bactericidal for the majority of strains.

Dosage & Administration

Patients who commence treatment on the parenteral formulation may be switched to oral presentation when clinically indicated. In such circumstances, no dose adjustment is required as Linezolid has an oral bioavailability of approximately 100%. The injection should be administered over a period of 30 to 120 minutes. The film-coated tablets or oral suspension may be taken with or without food.

Complicated skin and skin structure infections, Community-acquired pneumonia, including concurrent bacteremia-
  • Pediatric Patients (Birth through 11 Years of Age): 10 mg/kg IV or oral t.i.d.
  • Adults and Adolescents (12 Years and Older): 600 mg IV or oral b.i.d.
  • Recommended Duration of Treatment (consecutive days): 10 to 14
Nosocomial pneumonia, Vancomycin-resistant Enterococcus faecium infections including concurrent bacteremia-
  • Pediatric Patients (Birth through 11 Years of Age): 10 mg/kg IV or oral t.i.d.
  • Adults and Adolescents (12 Years and Older): 600 mg IV or oral b.i.d.
  • Recommended Duration of Treatment (consecutive days): 14 to 28
Uncomplicated skin and skin structure infections-
  • Pediatric Patients (Birth through 11 Years of Age): <5 yrs: 10 mg/kg oral t.i.d. 5-11 yrs: 10 mg/kg oral b.i.d
  • Adults and Adolescents (12 Years and Older): Adults: 400 mg oral b.i.d. Adolescents: 600 mg oral b.i.d
  • Recommended Duration of Treatment (consecutive days): 10 to 14
Neonates <7 days: Most pre-term neonates <7 days of age (gestational age <34 weeks) have lower systemic Linezolid clearance values and larger AUC values than many full-term neonates and older infants. These neonates should be initiated with a dosing regimen of 10 mg/kg every 12 hours. Consideration may be given to the use of 10 mg/kg in every eight hours regimen in neonates with a sub-optimal clinical response. All neonatal patients should receive 10 mg/kg t.i.d. by 7 days of life.

Interaction

Monoamine Oxidase Inhibition: Linezolid is a reversible and nonselective inhibitor of monoamine oxidase. Therefore, Linezolid has the potential for interaction with adrenergic and serotonergic agents.

Adrenergic Agents: Some individuals receiving Linezolid may experience a reversible enhancement of the pressor response to indirect-acting sympathomimetic agents, vasopressor or dopaminergic agents. Initial doses of adrenergic agents such as dopamine or epinephrine should be reduced and titrated to achieve the desired response.

Serotonergic Agents: Physicians should be alert to the possible signs and symptoms of serotonergic syndrome in patients receiving concomitant Linezolid and serotonergic agents.

Contraindications

Linezolid formulations are contraindicated for using in patients who have known hypersensitivity to Linezolid or any of the other product components. Linezolid should not be used in patients taking any medicinal product which inhibits monoamine oxidases A or B (e.g. Phenelzine, Isocarboxazid) or within two weeks of taking any such medicinal product. Linezolid should not be administered to patients with uncontrolled hypertension, pheochromocytoma, thyrotoxicosis, carcinoid syndrome and/or patients taking directly and indirectly acting sympathomimetic agents (e.g. Pseudoephedrine), vasopressive agents (e.g. Epinephrine, Norepinephrine), dopaminergic agents (e.g. Dopamine, Dobutamine), serotonin re-uptake inhibitors, tricyclic antidepressants, serotonin 5-HT1 receptor agonists (triptans), meperidine or buspirone.

Side Effects

Most of the adverse events reported with Linezolid were mild to moderate in intensity. The most common adverse events in patients treated with Linezolid were diarrhea, headache and nausea. Other adverse events includes oral moniliasis, vaginal moniliasis, hypertension, dyspepsia, localized abdominal pain, pruritus, and tongue discoloration.

Pregnancy & Lactation

Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. Linezolid should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not known whether Linezolid is excreted in human milk. Because many drugs are excreted in human milk. Caution should be exercised when Linezolid is administered to a nursing woman.

Precautions & Warnings

Patients who develop recurrent nausea or vomiting, unexplained acidosis or low bicarbonate level while receiving Linezolid should receive immediate medical evaluation. Where administration of Linezolid and concomitant serotonergic agents are clinically appropriate, patients should be closely observed for signs and symptoms of serotonin syndrome such as cognitive dysfunction, hyperpyrexia, hyperreflexia and incoordination. If signs or symptoms occur, physicians should consider discontinuation of either one or both agents. If the concomitant serotonergic agent is withdrawn, discontinuation symptoms can be observed. If patients experience symptoms of visual impairment, such as changes in visual acuity, changes in color vision, blurred vision or visual field defect, prompt ophthalmic evaluation is recommended. Convulsions have been reported in patients when treated with Linezolid. In some of these cases, a history of seizures or risk factors for seizures was reported.

Overdose Effects

No cases of overdose have been reported. Symptomatic and supportive care is advised together with maintenance of glomerular filtration. Approximately 30% of a Linezolid dose is removed during 3 hours of haemodialysis. No data are available for the removal of Linezolid by peritoneal dialysis or haemoperfusion.

Storage Conditions

Linezolid formulations should be stored at room temperature (15°C-30°C), away from light and moisture. All medicines should be kept away from children.

Alternative brands of Linezolid

Other brands with the same generic name, cheapest first.

Anulid Tablet

400 mg

Linezolid

Healthcare Pharmaceuticals Ltd.

৳ 60.00 per unit

Arlin Tablet

400 mg

Linezolid

Beximco Pharmaceuticals Ltd.

৳ 60.00 per unit

Ezolid Tablet

400 mg

Linezolid

Advanced Chemical Industries PLC

৳ 60.00 per unit

Anulid Tablet

600 mg

Linezolid

Healthcare Pharmaceuticals Ltd.

৳ 85.00 per unit

Arlin Tablet

600 mg

Linezolid

Beximco Pharmaceuticals Ltd.

৳ 85.00 per unit

Ezolid Tablet

600 mg

Linezolid

Advanced Chemical Industries PLC

৳ 85.00 per unit

Lizen Tablet

600 mg

Linezolid

Zenith Pharmaceuticals Ltd.

৳ 85.00 per unit

See all 39 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.